Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Evira Study: Additional Support During Anti-Obesity Treatment
Sponsor: Karolinska Institutet
Summary
The goal of this clinical trial is to evaluate the effect of adding a digi-physical treatment tool as a complement to the local treatment with anti-obesity medication in adolescents with obesity. The main question it aims to answer is: \- Can a combination of a digi-physical treatment tool and anti-obesity medication improve treatment outcomes for patients with obesity compared to patients treated with anti-obesity medications alone? This is a randomized controlled two-arm multicenter study where participants will be randomized to the intervention group (digi-physical treatment+medication) or control group (medication only). Participants will be followed for six months.
Official title: Evaluation of a Digital Treatment Tool in Combination With Anti-Obesity Medications
Key Details
Gender
All
Age Range
12 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-10-07
Completion Date
2026-10
Last Updated
2025-10-06
Healthy Volunteers
No
Conditions
Interventions
Digi-physical treatment tool, Evira
A digi-physical treatment tool named Evira will be used to provide behavioral treatment.
Anti-obesity medication with liraglutide or semaglutide
Anti-obesity medication with liraglutide or semaglutide according to the clinic's standard procedure
Locations (1)
HKH Crown Princess Victoria's Childrens and youth Hospital Linköping
Linköping, Sweden